SCHEMBL1897888

SCHEMBL1897888

CC(C)O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.54
LMNA P02545 1/20 0.54
MAPT P10636 1/20 0.50
BCHE P06276 3/20 0.37
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24137980 1.00 THRB (0.54) THRBLMNAMAPTBCHEALDH1A1
SCHEMBL25736461 1.00 THRB (0.54) THRBLMNAMAPTBCHEALDH1A1
SCHEMBL21097627 1.00 THRB (0.54) THRBLMNAMAPTBCHEALDH1A1
SCHEMBL20912079 1.00 THRB (0.54) THRBLMNAMAPTBCHEALDH1A1
SCHEMBL18959379 1.00 THRB (0.54) THRBLMNAMAPTBCHEALDH1A1
SCHEMBL23895333 0.87 ALDH1A1 (0.39) MAPTBCHEALDH1A1
SCHEMBL21159681 0.87 ALDH1A1 (0.39) MAPTBCHEALDH1A1
SCHEMBL23895358 0.87 ALDH1A1 (0.39) MAPTBCHEALDH1A1
SCHEMBL21399717 0.87 ALDH1A1 (0.39) MAPTBCHEALDH1A1
SCHEMBL23895364 0.87 ALDH1A1 (0.39) MAPTBCHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070020200-A1 Therapeutic compositions and methods of use thereof HODOSH MILTON 2007-01-25 US claimed
US-7115252-B2 Therapeutic compositions and methods of use thereof HODOSH MILTON 2006-10-03 US claimed
US-20030003163-A1 Therapeutic compositions and methods of use thereof HODOSH MILTON (US) 2003-01-02 US claimed
EP-0186276-B1 ORAL HYGIENE COMPOSITION ICI AMERICAS INC. (US) 1990-11-22 EP claimed
US-4632937-A MONG-AND DIALKYL ETHERS OF DIANHYDROHEXITOLS ICI AMERICAS (US) 1986-12-30 US claimed
US-4627979-A MONOALKYL AND DIALKYL ETHERS OF DIANHYDROHEXITOLS ICI AMERICAS INC. (US) 1986-12-09 US claimed
US-4627974-A CHEWING GUM WITH MONOALKYL AND DIALKYL DIANHYDROHEXITOLS ICI AMERICAS INC. (US) 1986-12-09 US claimed
US-4627975-A MONO AND DIALKYLETHERS OF DIANHYDROHEXITOLS ICI AMERICAS INC. (US) 1986-12-09 US claimed
US-4627976-A Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation ICI AMERICAS INC. (US) 1986-12-09 US claimed
US-4627980-A MONOALKYL AND DIALKYL ETHERS OF DIANHYDROHEXITOLS ICI AMERICAS INC. (US) 1986-12-09 US claimed
US-4627978-A Tooth drop dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation ICI AMERICAS INC. (US) 1986-12-09 US claimed
US-4610871-A Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation ICI AMERICAS INC. (US) 1986-09-09 US claimed
US-4610872-A Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation ICI AMERICAS INC. (US) 1986-09-09 US claimed
EP-0186276-A2 Oral hygiene composition ICI AMERICAS INC. (US) 1986-07-02 EP claimed
US-4585649-A MONO- AND DIALKYL ETHERS OF DIANHYDROHEXITOLS ICI AMERICAS INC. (US) 1986-04-29 US claimed
US-12012416-B2 Compositions and methods for treating atopic dermatitis SYTHEON LTD (US) 2024-06-18 US disclosed
US-11903990-B2 Compositions and methods for treating and removing seborrheic keratoses STOECKER WILLIAM VAN DOVER (US) 2024-02-20 US disclosed
US-4610871-A Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation ICI AMERICAS INC. (US) 1986-09-09 US disclosed
EP-0186276-A2 Oral hygiene composition ICI AMERICAS INC. (US) 1986-07-02 EP disclosed
US-4585649-A MONO- AND DIALKYL ETHERS OF DIANHYDROHEXITOLS ICI AMERICAS INC. (US) 1986-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11903990-B2 Compositions and methods for treating and removing seborrheic keratoses CAT, CUTA, GPX1 THRB 4313/4885LMNA 697/4885MAPT 3500/4885
US-12012416-B2 Compositions and methods for treating atopic dermatitis EBP, TSLP, COL14A1 THRB 4351/4885LMNA 2532/4885MAPT 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.